Meni-Med

Company Overview

Snapshot

Founded in December 2010 by Yossi De Levy and Dr. David Michaeli, Meni-Med operates with 1–10 employees. The company has secured one funding round from one investor. Meni-Med successfully carried out clinical trials for its device at the Assaf Harofeh Medical Center, under Helsinki approval.

Business overview

Meni-Med is a Health Tech & Life Sciences company focused on developing medical devices for minimally invasive surgical procedures. Its core product is a disposable and radiolucent spinal retractor designed to reduce paraspinal tissue damage and post-operative pain. The technology features micron retraction capability, small incisions, controlled access to the surgical site, multi-level access, illuminated optimal visibility, and recording capabilities. Meni-Med serves healthcare providers, hospitals, and surgeons in the United States and Europe, aiming to improve patient recovery and surgical efficiency.

Company Intelligence Q&A

What is Meni-Med's primary product?

Meni-Med develops a disposable and radiolucent spinal retractor specifically designed for minimally invasive surgical procedures, aiming to reduce paraspinal tissue damage and post-operative pain.

Who are the founders of Meni-Med?

Meni-Med was founded by Yossi De Levy and Dr. David Michaeli.

What markets does Meni-Med target?

Meni-Med targets the United States and Europe with its medical device solutions.

What is the current product stage of Meni-Med's device?

Meni-Med's device is currently in the clinical trial stage. Clinical trials were successfully carried out at the Assaf Harofeh Medical Center, under Helsinki approval.

Has Meni-Med secured any patents for its technology?

Initial prototypes of Meni-Med's device have been granted patents from the United States and Europe, with further patents pending.